Intuitive Surgical

Intuitive Surgical EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intuitive Surgical (ISRG) as of Oct 17, 2026 is 2.95 B USD. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 2.35 B USD — a change of 25.30% (higher).

EBITDA

2.95 BUSD

YoY

25.30%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intuitive Surgical is 2025 2.95 B USD. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intuitive Surgical was 2024 2.35 B USD. It decreases by 25.30% higher compared to the previous year.

The Intuitive Surgical EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
1.20 B USD
Jan 1, 2019
1.37 B USD
Jan 1, 2020
1.05 B USD
Jan 1, 2021
1.83 B USD
Jan 1, 2022
1.58 B USD
Jan 1, 2023
1.77 B USD
Jan 1, 2024
2.35 B USD
Jan 1, 2025
2.95 B USD
The Intuitive Surgical EBITDA history
YEAREBITDAYoY
2.95 BUSD+25.30%
2.35 BUSD+32.83%
1.77 BUSD+11.82%
1.58 BUSD-13.42%
1.83 BUSD+74.16%
1.05 BUSD-23.62%
1.37 BUSD+14.60%
1.20 BUSD+13.73%
1.05 BUSD+11.57%
945.20 MUSD+27.73%
740.00 MUSD+35.83%
544.80 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Intuitive Surgical Stock analysis

What does Intuitive Surgical do? Intuitive Surgical Inc is an American company that specializes in the manufacturing of medical robots. The company was founded by Friedman and Green in 1995 and is headquartered in Sunnyvale, California. Starting with the goal of improving and making laparoscopic surgery more efficient, the company has since expanded its offerings and distributes its robots in many countries worldwide. Intuitive Surgical's business model is based on surgeons purchasing the robots and, in some cases, operating them. The cost of a robot can be very high, but this is balanced out by the efficiency achieved through the use of the robots. One of the main advantages of Intuitive Surgical is the fact that the robots have higher precision than traditional surgery. There is less blood loss, less scarring, and therefore a shorter recovery time for the patient. The company has two main products, the Da Vinci System for laparoscopic surgery and the Ion Robotic System for endoscopy. The Da Vinci robot was Intuitive Surgical's first product and was introduced to the market in 2000. The Da Vinci robots are used for a variety of surgeries and provide better visualization and precision for the surgeon. The robot is operated through a console at which the surgeon sits and connects to the robot's instruments. The Ion robot, on the other hand, was recently introduced and is meant for endoscopy. The system offers more precise imaging and the ability to better position the endoscope. The robot also has the capability to extract and analyze biological samples and tissues from the patient. Intuitive Surgical also offers a variety of accessories, such as instruments, consoles, docking stations, and software. The instruments vary depending on the application, ranging from scissors and needle holders to graspers and clippers. The docking stations allow for automatic switching of instruments without the surgeon having to manually change them. The software is used to facilitate the control of the robots and instruments and support data processing. Since its founding in the 1990s, Intuitive Surgical has experienced impressive growth. In 2000, the company had only 14 employees and introduced the Da Vinci robot. Today, the company employs over 5,000 people and sells its products in more than 60 countries worldwide. The company has become a market leader in laparoscopic surgery and has won a variety of awards and accolades. The company is also highly committed to research and development. There is a team of engineers, scientists, and surgeons constantly working to improve the robots and instruments and develop new applications. Intuitive Surgical also has partnerships with leading healthcare companies in the industry to promote collaboration and knowledge exchange. Overall, Intuitive Surgical has had a significant impact on medical care and laparoscopic surgery. The company's robots have already helped many patients receive better medical care and recover faster. Collaboration with other industry experts and ministries also helps optimize the use of the technology and improve patient access to this technology. Intuitive Surgical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Intuitive Surgical stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intuitive Surgical is 2.95 B USD in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Intuitive Surgical changed from 2.35 B USD to 2.95 B USD, representing a 25.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Intuitive Surgical since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Intuitive Surgical historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Intuitive Surgical

All Key Metrics — Intuitive Surgical